Jun Ye
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery 5
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 8
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 6
- Immunology top 10%
- Immunotherapy and Immune Responses 7
- Immune cells in cancer 7
- Pharmacology top 5%
- Flavonoids in Medical Research 5
-
- Nanoplatforms for cancer theranostics 8
-
- RNA Interference and Gene Delivery 5
- Journals
- Acta Pharmaceutica Sinica B (5 papers)Journal of Pharmaceutical Analysis (4 papers)International Journal of Nanomedicine (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jun Ye
61 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Pharmaceutical Science 161
- Biomaterials 238
- Cancer Research 231
- Immunology 255
- Pharmacology 186
Countries citing papers authored by Jun Ye
This map shows the geographic impact of Jun Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ye more than expected).
Fields of papers citing papers by Jun Ye
This network shows the impact of papers produced by Jun Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ye. The network helps show where Jun Ye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jun Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 35 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 25 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 72 | |
| 15 | 2019 | 66 | |
| 16 | 2018 | 20 | |
| 17 | 2016 | 30 | |
| 18 | 2016 | 57 | |
| 19 | 2016 | 33 | |
| 20 | 2015 | 3 |
About Jun Ye
Jun Ye is a scholar working on Biomaterials, Pharmaceutical Science and Cancer Research, having authored 67 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (8 papers), Immunotherapy and Immune Responses (7 papers), Immune cells in cancer (7 papers), Cancer, Lipids, and Metabolism (6 papers), RNA Interference and Gene Delivery (5 papers), Flavonoids in Medical Research (5 papers) and Advancements in Transdermal Drug Delivery (5 papers). The work is most often cited by research in Pharmaceutical Science (161 citations), Biomaterials (238 citations) and Cancer Research (231 citations). Jun Ye has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuling Liu, Hengfeng Liao, Lili Gao, Yanfang Yang, Wujun Dong, Xuejun Xia, Yuling Liu, Chunpeng Zhu, Caihua Wang and Yue Gao. Their work appears in journals such as Acta Pharmaceutica Sinica B, Journal of Pharmaceutical Analysis, International Journal of Nanomedicine, Frontiers in Immunology and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.